Donald Gardenier - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Donald Gardenier

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Hepatology (Baltimore, Md.)|July 29, 2014

Costs of telaprevir-based triple therapy for hepatitis C: $189,000 per sustained virological responseKian Bichoupan, Valerie Martel-Laferriere, David Sachs, et al.

World Journal of Hepatology|May 5, 2017

Factors associated with success of telaprevir- and boceprevir-based triple therapy for hepatitis C virus infectionKian Bichoupan, Neeta Tandon, Valerie Martel-Laferriere, et al.

World Journal of Gastroenterology|March 15, 2016

Hepatic decompensation/serious adverse events in post-liver transplantation recipients on sofosbuvir for recurrent hepatitis C virusNeal Patel, Kian Bichoupan, Lawrence Ku, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Hepatology (Baltimore, Md.)|July 29, 2014

Costs of telaprevir-based triple therapy for hepatitis C: $189,000 per sustained virological responseKian Bichoupan, Valerie Martel-Laferriere, David Sachs, et al.

World Journal of Hepatology|May 5, 2017

Factors associated with success of telaprevir- and boceprevir-based triple therapy for hepatitis C virus infectionKian Bichoupan, Neeta Tandon, Valerie Martel-Laferriere, et al.

World Journal of Gastroenterology|March 15, 2016

Hepatic decompensation/serious adverse events in post-liver transplantation recipients on sofosbuvir for recurrent hepatitis C virusNeal Patel, Kian Bichoupan, Lawrence Ku, et al.

Pageof 2